These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33855061)

  • 1. Targeted therapy in eosinophilic chronic obstructive pulmonary disease.
    Fieldes M; Bourguignon C; Assou S; Nasri A; Fort A; Vachier I; De Vos J; Ahmed E; Bourdin A
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 33855061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Eosinophilic chronic obstructive pulmonary disease: A review].
    Anaev EK
    Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.
    George L; Brightling CE
    Ther Adv Chronic Dis; 2016 Jan; 7(1):34-51. PubMed ID: 26770668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease.
    Yi X; Li Y; Liu H; Liu X; Yang J; Gao J; Yang Y; Liang Z; Wang F; Chen D; Wang L; Shi W; Lam DCL; Stampfli MR; Jones PW; Chen R; Wang Z
    Microbiol Spectr; 2022 Apr; 10(2):e0259321. PubMed ID: 35311590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!
    Bel EH; Ten Brinke A
    Chest; 2017 Dec; 152(6):1276-1282. PubMed ID: 28583618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IL-5 in COPD.
    Narendra DK; Hanania NA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1045-1051. PubMed ID: 31190789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD and biologic treatment: state of the art.
    Ferri S; Paoletti G; Pelaia C; Heffler E; Canonica GW; Puggioni F
    Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):309-318. PubMed ID: 37357768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
    Zhang C; Wang Y; Zhang M; Su X; Lei T; Yu H; Liu J
    Front Pharmacol; 2021; 12():754268. PubMed ID: 34795588
    [No Abstract]   [Full Text] [Related]  

  • 9. Eosinophilic airway disorders.
    Scott KA; Wardlaw AJ
    Semin Respir Crit Care Med; 2006 Apr; 27(2):128-33. PubMed ID: 16612763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases?
    Magnussen H; Richter K; Taube C
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():187-94; discussion 203-5. PubMed ID: 9988466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.
    Aoshiba K; Nagai A
    Clin Rev Allergy Immunol; 2004 Aug; 27(1):35-43. PubMed ID: 15347849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cells and chronic obstructive pulmonary disease.
    Tetley TD
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):607-18. PubMed ID: 17305517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease of the airways in chronic obstructive pulmonary disease.
    Cosio Piqueras MG; Cosio MG
    Eur Respir J Suppl; 2001 Dec; 34():41s-49s. PubMed ID: 12392034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of eosinophilic COPD and pneumonia in post-treatment pulmonary multidrug-resistant tuberculosis patient: A case report.
    Maranatha D; Julian Parade NN
    Respir Med Case Rep; 2019; 28():100936. PubMed ID: 31667072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease in a new concept.
    Murărescu ED; Mitrofan EC; Mihailovici MS
    Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease.
    Mkorombindo T; Dransfield MT
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1779-1787. PubMed ID: 31496677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 20. The Relationship between Airway Inflammation and Exacerbation in Chronic Obstructive Pulmonary Disease.
    Perng DW; Chen PK
    Tuberc Respir Dis (Seoul); 2017 Oct; 80(4):325-335. PubMed ID: 28905537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.